DUBLIN, October 14, 2021--(BUSINESS WIRE)--The "Nasal Drug Delivery Technology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Nasal Drug Delivery Technology Market to Reach $73.3 Billion by 2027
Amid the COVID-19 crisis, the global market for Nasal Drug Delivery Technology estimated at US$51.6 Billion in the year 2020, is projected to reach a revised size of US$73.3 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027.
Nasal Sprays, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$40 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drops & Liquids segment is readjusted to a revised 4.4% CAGR for the next 7-year period.
The U.S. Market is Estimated at $15.2 Billion, While China is Forecast to Grow at 4.8% CAGR
The Nasal Drug Delivery Technology market in the U.S. is estimated at US$15.2 Billion in the year 2020. China, the world`s second-largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
Other Dosage Forms Segment to Record 2.5% CAGR
In the global Other Dosage Forms segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$4.2 Billion in the year 2020 will reach a projected size of US$5 Billion by the close of the analysis period. China will remain among the fastest-growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$8.4 Billion by the year 2027.
Select Competitors (Total 47 Featured):
Aegis Therapeutics LLC
Johnson & Johnson
Merck & Co., Inc.
Novartis International AG
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Total Companies Profiled: 47
For more information about this report visit https://www.researchandmarkets.com/r/gqf9tm
View source version on businesswire.com: https://www.businesswire.com/news/home/20211014005585/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900